Problemy kardiologiczne w reumatoidalnym zapaleniu stawów Artykuł przeglądowy
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
wrz 30, 2018
Słowa kluczowe:
choroba niedokrwienna serca, niewydolność serca, reumatoidalne zapalenie stawów, wady zastawek serca, zaburzenia rytmu i przewodzenia, zapalenie osierdzia
##plugins.themes.bootstrap3.article.main##
Abstrakt
Reumatoidalne zapalenie stawów (RZS) jest zapalną, autoimmunologiczną chorobą tkanki łącznej charakteryzującą się zajęciem małych i średnich stawów, a także występowaniem zmian pozastawowych, w tym w układzie sercowo-naczyniowym. U pacjentów z RZS stwierdzono większą skłonność do zachorowania na zapalenie osierdzia, chorobę niedokrwienną serca, niewydolność serca, wady zastawek oraz zaburzenia rytmu i przewodzenia. Zajęcie układu sercowo-naczyniowego jest częste i przyczynia się do zwiększenia śmiertelności chorych na RZS, dlatego też niezwykle istotne są: prawidłowa ocena oraz kontrola czynników ryzyka sercowo-naczyniowego, wczesne wykrywanie powikłań i ich leczenie w tej grupie.
##plugins.themes.bootstrap3.article.details##
Jak cytować
Świderska, A., Wojciechowska , M., Mamcarz , A., & Cudnoch-Jędrzejewska, A. (2018). Problemy kardiologiczne w reumatoidalnym zapaleniu stawów . Medycyna Faktów , 9(3(32), 206-210. Pobrano z https://journalsmededu.pl/index.php/jebm/article/view/2220
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Aletaha D., Neogi T., Silman A.J. et al.: 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis. 2010; 69: 1580-1588.
2. Ahlmén M., Svensson B., Albertsson K. et al.: Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage. Ann. Rheum. Dis. 2010; 69: 230-233.
3. Nowak B.: Adalimumab w RZS. Przegląd Reumatologiczny 2007; 2: 1-2.
4. Stachowicz K., Śliwińska-Stańczyk P., Łącki J.K.: Znaczenie badania echokardiograficznego w ocenie patologii układu sercowo-naczyniowego u pacjentów z reumatoidalnym zapaleniem stawów. Reumatologia 2009; 47: 82-84.
5. Kitas G., Banks M.J., Bacon P.A.: Cardiac involvement in rheumatoid disease. Clin. Med. 2001; 1: 18-21.
6. Van der Heide A., Jacobs J.W., Bijlsma J.W. et al.: The effectiveness of early treatment with second line anti-rheumatic drugs; a randomized, controlled trial. Ann. Int. Med. 1996; 124: 699-707.
7. Solomon D.H., Goodson N.J., Katz J.N. et al.: Patterns of cardiovascular risk in rheumatoid arthritis. Ann. Rheum. Dis. 2006; 65: 1608-1612.
8. Maradit-Kremers H., Crowson C.S., Nicola P.J. et al.: Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005; 52: 402-411.
9. Krishnan E., Lingala V.B., Singh G.: Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 2004; 110: 1774-1779.
10. Goodson N.J., Symmons D.P., Scott D.G. et al.: Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year follow-up study of a primary care-based inception cohort. Arthritis Rheum. 2005; 52: 2293-2299.
11. Maradit-Kremers H., Nicola P.J., Crowson C.S. et al.: Cardiovascular death in rheumatoid arthritis: a popu-lation-based study. Arthritis Rheum. 2005; 52: 722-732.
12. Turesson C., McClelland R.L., Christianson T.J. et al.: Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2007; 66: 70-75.
13. Gonzalez-Juanatey C., Llorca J., Testa A. et al.: Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 2003; 82: 407-413.
14. Doria A., Shoenfeld Y., Wu R. et al.: Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann. Rheum. Dis. 2003; 62: 1071-1077.
15. Douglas K.M., Pace A.V., Treharne G.J. et al.: Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann. Rheum. Dis. 2006; 65: 348-353.
16. Banks M., Flint J., Bacon P.A. et al.: Rheumatoid arthritis is an independent risk factor for ischaemic heart disease. Arthritis Rheum. 2000; 43: 385.
17. Warrington K.J., Kent P.D., Frye R.L. et al.: Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res. Ther. 2005; 7: 984-991.
18. Choi H.K., Hernan M.A., Seeger J.D. et al.: Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002; 359: 1173-1177.
19. Micha R., Imamura F., Wyler von Ballmoos M. et al.: Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am. J. Cardiol. 2011; 108: 1362-1370.
20. Jamnitski A., Visman I.M., Peters M.J. et al.: Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study. Ann. Rheum. Dis. 2010; 69: 1929-1933.
21. MacGowan G.A., Mann D.L., Kormos R.L. et al.: Circulating interleukin-6 in severe heart failure. Am. J. Cardiol. 1997; 79: 1128-1131.
22. Rudominer R.L., Roman M.J., Devereux R.B. et al.: Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum. 2009; 60: 9-22.
23. Davis III J.M., Roger V.L., Crowson C.S. et al.: The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum. 2008; 9: 2603-2611.
24. Wislowska M., Sypula S., Kowalik I.: Echogcardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis. Rheumatol. Int. 1999; 18: 163-169.
25. Mandell B.F., Hoffman G.S.: Rheumatic diseases and the cardiovascular system. Braunwald’s Heart Disease. A Textbook of Cardiovascular Medicine. Elsevier Saunders, Philadelphia 2005: 2101-2116.
2. Ahlmén M., Svensson B., Albertsson K. et al.: Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage. Ann. Rheum. Dis. 2010; 69: 230-233.
3. Nowak B.: Adalimumab w RZS. Przegląd Reumatologiczny 2007; 2: 1-2.
4. Stachowicz K., Śliwińska-Stańczyk P., Łącki J.K.: Znaczenie badania echokardiograficznego w ocenie patologii układu sercowo-naczyniowego u pacjentów z reumatoidalnym zapaleniem stawów. Reumatologia 2009; 47: 82-84.
5. Kitas G., Banks M.J., Bacon P.A.: Cardiac involvement in rheumatoid disease. Clin. Med. 2001; 1: 18-21.
6. Van der Heide A., Jacobs J.W., Bijlsma J.W. et al.: The effectiveness of early treatment with second line anti-rheumatic drugs; a randomized, controlled trial. Ann. Int. Med. 1996; 124: 699-707.
7. Solomon D.H., Goodson N.J., Katz J.N. et al.: Patterns of cardiovascular risk in rheumatoid arthritis. Ann. Rheum. Dis. 2006; 65: 1608-1612.
8. Maradit-Kremers H., Crowson C.S., Nicola P.J. et al.: Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005; 52: 402-411.
9. Krishnan E., Lingala V.B., Singh G.: Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 2004; 110: 1774-1779.
10. Goodson N.J., Symmons D.P., Scott D.G. et al.: Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year follow-up study of a primary care-based inception cohort. Arthritis Rheum. 2005; 52: 2293-2299.
11. Maradit-Kremers H., Nicola P.J., Crowson C.S. et al.: Cardiovascular death in rheumatoid arthritis: a popu-lation-based study. Arthritis Rheum. 2005; 52: 722-732.
12. Turesson C., McClelland R.L., Christianson T.J. et al.: Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2007; 66: 70-75.
13. Gonzalez-Juanatey C., Llorca J., Testa A. et al.: Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 2003; 82: 407-413.
14. Doria A., Shoenfeld Y., Wu R. et al.: Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann. Rheum. Dis. 2003; 62: 1071-1077.
15. Douglas K.M., Pace A.V., Treharne G.J. et al.: Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann. Rheum. Dis. 2006; 65: 348-353.
16. Banks M., Flint J., Bacon P.A. et al.: Rheumatoid arthritis is an independent risk factor for ischaemic heart disease. Arthritis Rheum. 2000; 43: 385.
17. Warrington K.J., Kent P.D., Frye R.L. et al.: Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res. Ther. 2005; 7: 984-991.
18. Choi H.K., Hernan M.A., Seeger J.D. et al.: Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002; 359: 1173-1177.
19. Micha R., Imamura F., Wyler von Ballmoos M. et al.: Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am. J. Cardiol. 2011; 108: 1362-1370.
20. Jamnitski A., Visman I.M., Peters M.J. et al.: Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study. Ann. Rheum. Dis. 2010; 69: 1929-1933.
21. MacGowan G.A., Mann D.L., Kormos R.L. et al.: Circulating interleukin-6 in severe heart failure. Am. J. Cardiol. 1997; 79: 1128-1131.
22. Rudominer R.L., Roman M.J., Devereux R.B. et al.: Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum. 2009; 60: 9-22.
23. Davis III J.M., Roger V.L., Crowson C.S. et al.: The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum. 2008; 9: 2603-2611.
24. Wislowska M., Sypula S., Kowalik I.: Echogcardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis. Rheumatol. Int. 1999; 18: 163-169.
25. Mandell B.F., Hoffman G.S.: Rheumatic diseases and the cardiovascular system. Braunwald’s Heart Disease. A Textbook of Cardiovascular Medicine. Elsevier Saunders, Philadelphia 2005: 2101-2116.